Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1

被引:691
|
作者
Cummings, CJ
Mancini, MA
Antalffy, B
DeFranco, DB
Orr, HT
Zoghbi, HY [1 ]
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[5] Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA
[6] Howard Hughes Med Inst, Houston, TX 77030 USA
[7] Univ Pittsburgh, Dept Biol Sci & Pharmacol, Pittsburgh, PA USA
[8] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[9] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA
[10] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA
关键词
D O I
10.1038/502
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by expansion of a polyglutamine tract in ataxin-1. In affected neurons of SCA1 patients and transgenic mice, mutant ataxin-1 accumulates in a single, ubiquitin-positive nuclear inclusion. In this study, we show that these inclusions stain positively for the 205 proteasome and the molecular chaperone HDJ-2/HSDJ. Similarly, HeLa cells transfected with mutant ataxin-1 develop nuclear aggregates which colocalize with the 205 proteasome and endogenous HDJ-2/HSDJ. Overexpression of wild-type HDJ-2/HSDJ in HeLa cells decreases the frequency of ataxin-1 aggregation. These data suggest that protein misfolding is responsible for the nuclear aggregates seen in SCA1, and that over-expression of a DnaJ chaperone promotes the recognition of a misfolded polyglutamine repeat protein, allowing its refolding and/or ubiquitin-dependent degradation.
引用
收藏
页码:148 / 154
页数:7
相关论文
共 11 条
  • [1] Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
    Christopher J. Cummings
    Michael A. Mancini
    Barbara Antalffy
    Donald B. DeFranco
    Harry T. Orr
    Huda Y. Zoghbi
    Nature Genetics, 1998, 19 : 148 - 154
  • [2] Molecular pathogenesis of a polyglutamine neurological disease: nuclear localization and aggregation in SCA1 transgenic mice
    Skinner, PJ
    Klement, IA
    Clark, HB
    Zoghbi, HY
    Orr, HT
    BRAIN RESEARCH, 1998, 809 (01) : A11 - A11
  • [3] Ataxin-1 nuclear localization and aggregation:: Role in polyglutamine-induced disease in SCA1 transgenic mice
    Klement, IA
    Skinner, PJ
    Kaytor, MD
    Yi, H
    Hersch, SM
    Clark, HB
    Zoghbi, HY
    Orr, HT
    CELL, 1998, 95 (01) : 41 - 53
  • [4] Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
    Kourkouta, Eleni
    Weij, Rudie
    Gonzalez-Barriga, Anchel
    Mulder, Melissa
    Verheul, Ruurd
    Bosgra, Sieto
    Groenendaal, Bas
    Puolivali, Jukka
    Toivanen, Jussi
    van Deutekom, Judith C. T.
    Datson, Nicole A.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 17 : 601 - 614
  • [5] Evidence for proteasome involvement in polyglutamine disease:: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
    Chai, YH
    Koppenhafer, SL
    Shoesmith, SJ
    Perez, MK
    Paulson, HL
    HUMAN MOLECULAR GENETICS, 1999, 8 (04) : 673 - 682
  • [6] Glial S100B Protein Modulates Mutant Ataxin-1 Aggregation and Toxicity: TRTK12 Peptide, a Potential Candidate for SCA1 Therapy
    Parminder J. S. Vig
    Scoty Hearst
    Qingmei Shao
    Mariper E. Lopez
    Henry A. Murphy
    Eshan Safaya
    The Cerebellum, 2011, 10 : 254 - 266
  • [7] Glial S100B Protein Modulates Mutant Ataxin-1 Aggregation and Toxicity: TRTK12 Peptide, a Potential Candidate for SCA1 Therapy
    Vig, Parminder J. S.
    Hearst, Scoty
    Shao, Qingmei
    Lopez, Mariper E.
    Murphy, Henry A., II
    Safaya, Eshan
    CEREBELLUM, 2011, 10 (02): : 254 - 266
  • [8] Screening for small molecule modulators of Hsp70 chaperone activity using protein aggregation suppression assays: inhibition of the plasmodial chaperone PfHsp70-1
    Cockburn, Ingrid L.
    Pesce, Eva-Rachele
    Pryzborski, Jude M.
    Davies-Coleman, Michael T.
    Clark, Peter G. K.
    Keyzers, Robert A.
    Stephens, Linda L.
    Blatch, Gregory L.
    BIOLOGICAL CHEMISTRY, 2011, 392 (05) : 431 - 438
  • [9] cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1
    Hoang, T
    Fenne, IS
    Cook, C
    Borud, B
    Bakke, M
    Lien, EA
    Mellgren, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 49120 - 49130
  • [10] SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization
    Wiertelak, Wojciech
    Chabowska, Karolina
    Szulc, Bozena
    Zadorozhna, Yelyzaveta
    Olczak, Mariusz
    Maszczak-Seneczko, Dorota
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2023, 1870 (05):